Tübingen, Germany

Susanne Rauch

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 149(Granted Patents)


Location History:

  • Tübingen, DE (2021 - 2024)
  • Tubingen, DE (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Innovations in Vaccination: The Contributions of Susanne Rauch**

Introduction

Susanne Rauch, a prominent inventor based in Tübingen, Germany, has made significant contributions to the field of biotechnology, particularly in the development of innovative vaccines. With a prolific record of 18 patents, her work continues to push the boundaries of medical science, focusing on viral infections and prevention strategies.

Latest Patents

Rauch's latest innovations include two notable patents. The first is centered around **RSV RNA molecules and compositions for vaccination**. This invention involves an artificial nucleic acid, specifically an artificial RNA designed for the treatment and prevention of infections caused by the Respiratory syncytial virus (RSV). The patent outlines methods to treat or prevent related disorders and includes medical uses, compositions, and vaccines, along with a kit featuring these components.

The second patent focuses on **Rotavirus vaccines**, which encompasses mRNA sequences that encode epitopes of rotavirus proteins. This innovation offers a promising approach to creating vaccines or pharmaceutical compositions that can effectively prevent or treat rotavirus infections, marking a significant advancement in the field.

Career Highlights

Susanne Rauch has garnered experience and expertise through her work at notable companies, including CureVac SE and CureVac AG. Her career in the biopharmaceutical industry has enabled her to develop cutting-edge technologies that address pressing health challenges posed by viral diseases, showcasing her role as a leader in vaccine research.

Collaborations

Throughout her career, Rauch has collaborated with esteemed colleagues like Benjamin Petsch and Hans Wolfgang Große. These partnerships have fostered an environment of innovation, contributing to the success of her projects and the advancement of vaccine technology.

Conclusion

Susanne Rauch's dedication to the field of biotechnology and her extensive patent portfolio illustrate her commitment to enhancing public health through innovative vaccination strategies. Her contributions not only advance scientific knowledge but also pave the way for future developments in the prevention and treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…